top of page

2022 Rome Action Plan on Paediatric HIV & TB



All partners commit to: 


163. Address inequities by tackling the stigma and discrimination in communities, schools, and healthcare settings that prevent children living with HIV from accessing testing and treatment. 

164. Increase literacy about CD4 testing and viral load and promote a client-centred approach to support expansion of access to viral load for pregnant and breastfeeding women and children on treatment, including at the point-of-care. 

165. Review and assess emerging co-infections for immunocompromised infants and children, including those with advanced HIV disease, such as severe bacterial infections, fungal infections, and others for country consideration and implementation.

166. Engage affected communities for input and guidance on investment and programmatic priorities, provide support to in-country civil society organizations to engage in advocacy and demand creation for new tools, and ensure data is publicly available to support communities and civil society to monitor progress regarding uptake and implementation of essential diagnostic tools.




KNCV Tuberculosis Foundation commits to:

472. Work with country stakeholders to develop a platform and mechanism to ensure all commitments turn into action

473. Support countries to develop national strategic plans and Global Fund concept notes that are data driven and addressing the needs of children in the entire patient pathway. 

474. Collaborate and coordinate with in-country professional and regulatory bodies to ensure countries are prepared for early uptake of new innovations/medicines and develop a plan for scale up. 

475. Produce high quality documentation of our best practices and evidence to share at global platforms to guide global policies and guidelines.


476. Engage with civil society to create sense of urgency at country level to ensure all children needs related to TB/HIV are implemented

478. Support countries in scaling up the stool test with GeneXpert for TB diagnosis in children including development of generic SOP’s and training materials. 

479. Support countries to self-assess and quantify the programmatic implementation of WHO recommendations on the management of TB in children and adolescents



bottom of page